Jürgen Raths

Horizon Therapeutics Schweiz GmbH is a biopharmaceutical company that develops and commercializes medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The company was originally founded in 2004 as a spin-out of Merck KGaA and is headquartered in Reinach, Switzerland.

HBM Partners AG (HBM-P) was established in 2001 as an independent provider of investment advisory services with headquarters in Zug, Switzerland. HBM-P's field of expertise comprises global human medicine, biotechnology, medical technology and related sectors. The firm primarily advises HBM BioVentures AG and HBM BioCapital via their Cayman Islands-based, wholly-owned subsidiary, HBM Partners (Cayman) Ltd., which acts as the investment manager for the HBM funds. They rely on the services of an external consultant to analyze investment opportunities in the US.

Endress+Hauser AG manufactures measuring instruments and automation solutions for the industrial process engineering industry. The company was founded in 1953 and is headquartered in Reinach, Switzerland.

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Endress+Hauser Holding AG manufactures instrumentation and measurement systems. It offers instruments to control automation processes for analytics, flow measurement, level, pressure, and temperature fields. The firm provides inventory management, flow metering, analytical, filed networking engineering and plant asset management solutions, and supporting and optimizing services for oil and gas, power and energy, water and wastewater, life sciences, food and beverage, and chemical industries. The company was founded in 1953 and is headquartered in Reinach, Switzerland.

New Rhein Healthcare Investors LLC (New Rhein Healthcare Investors) is a private equity firm founded in 2010 by Parekh Greg. The firm is headquartered in Philadelphia, Pennsylvania.

Ferring GmbH is a German pharmaceutical company that manufactures pharmaceutical products. The private company is based in Kiel, Germany. The company was founded in 1990. The CEO is Claus Tollnick.

Ferring Pharmaceuticals Ltd. manufactures and produces pharmaceutical products. It offers Zomacton (somatropin) for that treatment of growth failure in children and for girl’s diagnosed with Turners syndrome; GONAPEPTYL (triptorelin), a GnRH agonist that is used for the treatment of children with central precocious puberty; Testim (testosterone gel), a hydroalcoholic topical gel; and PENTASA (mesalazine), which is used for the treatment of inflammatory bowel diseases. The company was founded in 1975 and is headquartered in Middlesex, the United Kingdom.

Ferring Pharmaceuticals SA develops and markets biopharmaceutical products. It provides products in the fields of reproductive health, urology, gastroenterology, endocrinology, and osteoarthritis. The company was founded by Frederik Paulsen Sr in 1950 and is headquartered in Saint-Prex, Switzerland.

Part of Ferring Holding SA, Ferring Holding, Inc. is a company that manufactures and sells pharmaceuticals. The company is based in Parsippany, NJ.

Hovione FarmaCiencia SA manufactures and distributes active pharmaceutical ingredients. Its services include contract manufacturing services, off-patent API products, proprietary product licensing, and supporting capabilities. The company was founded by Diane de Lancastre Houssemayne Du Boulay Villax, Ivan Villax, Nicholas de Horthy and Andrew Onody in 1959 and is headquartered in Loures, Portugal.

Ferring International Center SA develops, manufactures and markets products in the fields of urology, gynaecology and obstetrics. It also specializes in the fields of gastroenterology and endocrinology. The company was founded in 1950 and is headquartered in Saint-Prex, Switzerland.

Ferring Pharmaceuticals A/S specializes in the development, production and marketing of pharmaceutical products. It offers products in the fields of urology, infertility, obstetrics, gynecology, gastroenterology and maternal health. The company is headquartered in Copenhagen, Denmark.

EnteroBiotix Ltd. develops novel microbiome modulating drugs which are composed of live microorganisms. It focuses on faecal microbiota transplantation which transfers bacteria from a healthy donor into a recipient having an infection caused by a bacterium called C.difficile. The company was founded by James Roger McIlroy in March 2017 and is headquartered in Aberdeen, the United Kingdom.

Mindmaze, Inc. operates as a computing platform that captures brain activity. The firm develops medical virtual reality products for neural sicknesses. The firm offers MindMotion PRO, is FDA-cleared to bring 3D virtual environment therapy for neuro rehabilitation to patients. The company was founded by Tej Tadi in 2012 and is headquartered in San Francisco, CA.

Kuste Biopharma SAS engages in the development of therapies for unmet medical inflammatory. The company was founded in 2019 and is headquartered in Lyon, France.

HSBC Bank Plc (Broker) (HSBC Bank-Broker) is the broker/dealer division of HSBC Bank Plc, which is owned by HSBC Holdings Plc (LON: HSBA; NYSE: HSBC) in Great Britain. Headquartered in London, HSBC Bank-Broker was founded in 1880 and offers bespoke brokerage services across every major asset class for their corporate and institutional clients.

Vischer AG provides legal advisory services. The private company is based in Basel, Switzerland.

Firstquote, Inc. provides investor information services and online brokerage solutions. The company was founded in 1996 and is headquartered in Geneva, Switzerland.

Enexis AB is an investment company focusing on the European legal cannabis and plant based industries mainly in the wellness and health sectors. The company was founded by Carl-David Bonnier and Amaury de Poret and is headquartered in Stockholm Sweden.

ENEXIS AB (ENEXIS) is an independent venture capital firm founded in 2018 by David Bonnier. The firm is headquartered in Stockholm, Sweden.

Part of Valmiki Capital Management, Ceres 504 LLC operates as a food industry incubator.

Valmiki 504 LLC (Valmiki 504), subsidiary of Valmiki Capital Management LP, is a venture capital firm founded in 2015 by Ravi Suria. The firm is headquartered in New Orleans, Louisiana.

Clear Health Bill LLC provides health insurance services. The firm offers customizable plan choice, predictive analytics, advanced formulary and integrated deployment services. The company is headquartered in Stamford, CT.

The Focus Group provides real estate and business consulting services. The American company was founded by Doron Cohen, Neil Gibbons.

Propeller provides mobile application services. The company was founded by Clay Allsopp and Brian Rowen in 2013 and is headquartered in San Francisco, CA.

Better Digestive Health LLC markets functional food products with natural ingredients. It formulates ingredients in the correct portions to optimize nutrition and minimize common troublesome digestive symptoms. The company was founded by Vivek Huilgol and Neil Gibbons and is headquartered in New Orleans, LA.

Genpharm Services operates as a pharmaceutical company providing partners with market access and commercial solutions into the Middle East and North Africa region. It also acts as a commercial partner for rare genetic diseases, orphan drugs, and specialty therapeutics and offers strategic advice on disease areas, product launches and go-to markets strategies. The company was founded by Karim Smaira and Kamel Ghammachi in 2012 and is headquartered in Dubai, United Arab Emirates.

W. Söhngen GmbH engages in the development, production, and distribution of medical kits. It offers products for wound care as well as first aid and emergency medicine. The company is headquartered in Taunusstein, Germany.

Convert Pharmaceuticals SA provides preclinical stage drug development services. Its product hypoxia activated prodrug (HAP) is a therapeutic obstacle as it promotes the development of resistance to conventional anti-cancer treatments. The company was founded by Philippe Lambin, Nicolas Geuens, and Paul Tulcinsky on February 24, 2017 and is headquartered in Liege, Belgium.